Molecular Epidemiology of Global Carbapenemase-Producing spp. (2015-2017).

Microbiol Spectr

Alberta Precision Laboratories, Calgary, Alberta, Canada.

Published: February 2023

The emergence of carbapenem resistance is a significant public health concern. The rate of infections caused by carbapenemase-producing spp., particularly C. freundii, is increasing. Concomitantly, comprehensive global genomic data on carbapenemase-producing spp. are scarce. We used short read whole-genome sequencing to describe the molecular epidemiology and international distribution of eighty-six carbapenemase-producing spp. obtained from two surveillance programs (2015 to 17). The common carbapenemases were KPC-2 (26%), VIM-1 (17%), IMP-4 (14%) and NDM-1 (10%). C. freundii and C. portucalensis were the principal species. C. freundii consisted of multiple clones obtained mainly from Colombia (with KPC-2), the United States (with KPC-2, -3), and Italy (with VIM-1). Two dominant C. freundii clones were identified: ST98 was linked with from Taiwan and from the United States, and ST22 was linked with from Colombia and from Italy. C. portucalensis consisted mainly of two clones: ST493 with which was limited to Australia, and ST545 with which was limited to Turkey. Class I integron (In916) with was circulating between multiple sequence types (STs) in Italy, Poland, and Portugal. In73 with was circulating between various STs in Taiwan, while In809 with was circulating between different STs in Australia. The global carbapenemase-producing spp. population is dominated by diverse STs with different characteristics and varied geographical distribution and thus requires continued monitoring. Ongoing genomic surveillance should use methodologies able to distinguish between C. freundii and C. portucalensis. spp. are gaining recognition as important causes of hospital-acquired infections in humans. Among spp., carbapenemase-producing strains are cause of utmost concern to health care services globally due to their ability to resist therapy with virtually any beta-lactam antibiotic. Here, we described the molecular characteristics of a global collection of carbapenemase-producing spp. C. freundii and were the most common species among spp. with carbapenemases from this survey. Importantly, was misidentified as C. freundii when using Vitek 2.0MALDI-TOF MS (matrix-assisted laser desorption/ionization-time of flight mass spectrometry) phenotypic identification, which has important implications for future surveys. Among C. freundii, we identified two dominant clones: ST98 with from Taiwan and from the United States, and ST22 with from Colombia and from Italy. As for , the dominant clones consisted of ST493 with from Australia and ST545 with from Turkey.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101073PMC
http://dx.doi.org/10.1128/spectrum.04144-22DOI Listing

Publication Analysis

Top Keywords

carbapenemase-producing spp
24
united states
12
spp
9
molecular epidemiology
8
global carbapenemase-producing
8
freundii
8
spp freundii
8
freundii portucalensis
8
taiwan united
8
states st22
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!